GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 116 days ( 0 % )
Last Price $5.91 0 %
High/ Low $5.91 - $5.91 0%
Chg 7 Days N/A $5.91 $5.91
Chg 30 Days N/A $5.91 $5.91
Chg 12 mos -40.30 % $9.90 $5.91
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -53.48 % Width: 1,589.00 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - $3.90 -100.00 % - -33.95 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2022-02-17 - 125 days
Long MA avg 12 mos Sell 2021-11-02 - 199 days
Short/Long MA avg 12 mos Sell 2021-10-27 - 203 days
Pivot Short Sell 2022-08-16 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... EDGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT